PharmAbcine

Industry · 8 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 Advanced or Metastatic Solid Tumors	Phase 1	2024-01-03
Completed	Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degenerati Neovascular Age-related Macular Degeneration	Phase 1	2023-07-20
Terminated	Olinvacimab With Pembrolizumab in Patients With mTNBC Metastatic Triple-Negative Breast Cancer	Phase 2	2021-09-30
Terminated	TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab Recurrent Glioblastoma	Phase 2	2019-11-13
Unknown	TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma Recurrent Glioblastoma	Phase 1	2019-01-16
Unknown	TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer Triple Negative Breast Cancer	Phase 1	2019-01-03
Completed	Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma Recurrent Glioblastoma	Phase 2	2016-02-04
Completed	Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer Advanced Cancer, Metastatic Cancer	Phase 1	2011-11-01